Dynamics of the Cellular Metabolome during Human Cytomegalovirus Infection

Viral replication requires energy and macromolecular precursors derived from the metabolic network of the host cell. Despite this reliance, the effect of viral infection on host cell metabolic composition remains poorly understood. Here we applied liquid chromatography-tandem mass spectrometry to measure the levels of 63 different intracellular metabolites at multiple times after human cytomegalovirus (HCMV) infection of human fibroblasts. Parallel microarray analysis provided complementary data on transcriptional regulation of metabolic pathways. As the infection progressed, the levels of metabolites involved in glycolysis, the citric acid cycle, and pyrimidine nucleotide biosynthesis markedly increased. HCMV-induced transcriptional upregulation of specific glycolytic and citric acid cycle enzymes mirrored the increases in metabolite levels. The peak levels of numerous metabolites during infection far exceeded those observed during normal fibroblast growth or quiescence, demonstrating that HCMV markedly disrupts cellular metabolic homeostasis and institutes its own specific metabolic program.

[1]  J. Rabinowitz,et al.  Identifying decomposition products in extracts of cellular metabolites. , 2006, Analytical biochemistry.

[2]  Wenyun Lu,et al.  Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry. , 2006, Journal of chromatography. A.

[3]  James M. Roberts,et al.  A New Description of Cellular Quiescence , 2006, PLoS biology.

[4]  Joshua D. Rabinowitz,et al.  A high-performance liquid chromatography-tandem mass spectrometry method for quantitation of nitrogen-containing intracellular metabolites , 2006, Journal of the American Society for Mass Spectrometry.

[5]  J. Nielsen,et al.  Global metabolite analysis of yeast: evaluation of sample preparation methods , 2005, Yeast.

[6]  C. Boschek,et al.  Pyruvate kinase type M2 and its role in tumor growth and spreading. , 2005, Seminars in cancer biology.

[7]  Frederic D Sigoillot,et al.  Nuclear Localization and Mitogen-activated Protein Kinase Phosphorylation of the Multifunctional Protein CAD* , 2005, Journal of Biological Chemistry.

[8]  D. Michel,et al.  Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus. , 2005, The Journal of general virology.

[9]  D. W. Foster.  The Role of the Carnitine System in Human Metabolism , 2004, Annals of the New York Academy of Sciences.

[10]  I. H. Lambert.  Regulation of the Cellular Content of the Organic Osmolyte Taurine in Mammalian Cells , 2004, Neurochemical Research.

[11]  T. Ferenci,et al.  Global metabolite analysis: the influence of extraction methodology on metabolome profiles of Escherichia coli. , 2003, Analytical biochemistry.

[12]  L. Enquist,et al.  Construction of a Self-Excisable Bacterial Artificial Chromosome Containing the Human Cytomegalovirus Genome and Mutagenesis of the Diploid TRL/IRL13 Gene , 2002, Journal of Virology.

[13]  Thomas Shenk,et al.  Altered Cellular mRNA Levels in Human Cytomegalovirus-Infected Fibroblasts: Viral Block to the Accumulation of Antiviral mRNAs , 2001, Journal of Virology.

[14]  Z. Vančíková,et al.  Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review. , 2001, Current drug targets. Immune, endocrine and metabolic disorders.

[15]  P D Karp,et al.  Global properties of the metabolic map of Escherichia coli. , 2000, Genome research.

[16]  T. Shenk,et al.  Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Bucala,et al.  An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Hervé,et al.  Allosteric regulation and substrate channeling in multifunctional pyrimidine biosynthetic complexes: analysis of isolated domains and yeast-mammalian chimeric proteins. , 1998, Journal of molecular biology.

[19]  H. Al-Masri,et al.  Oscillations in Activities of Enzymes in Pancreatic Islet Subcellular Fractions Induced by Physiological Concentrations of Effectors , 1997, Diabetes.

[20]  D. Dittmer,et al.  Human cytomegalovirus infection inhibits G1/S transition , 1997, Journal of virology.

[21]  G. Hervé,et al.  In situ behavior of the pyrimidine pathway enzymes in Saccharomyces cerevisiae. 4. The channeling of carbamylphosphate to aspartate transcarbamylase and its partition in the pyrimidine and arginine pathways. , 1994, Archives of biochemistry and biophysics.

[22]  L. Hue,et al.  Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. , 1993, Advances in enzyme regulation.

[23]  H. Kole,et al.  Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts. , 1991, Archives of biochemistry and biophysics.

[24]  David R. Evans,et al.  Comparative modeling of mammalian aspartate transcarbamylase , 1991, Proteins.

[25]  A. Dickson,et al.  Control of glycolysis in cultured chick embryo hepatocytes. Fructose 2,6-bisphosphate content and phosphofructokinase-1 activity are stimulated by insulin and epidermal growth factor. , 1990, The Biochemical journal.

[26]  M. Rider,et al.  Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. , 1987, The Biochemical journal.

[27]  M. Landini,et al.  Early enhanced glucose uptake in human cytomegalovirus-infected cells. , 1984, The Journal of general virology.

[28]  G. Hervé,et al.  In situ behavior of the pyrimidine pathway enzymes in Saccharomyces cerevisiae. I. Catalytic and regulatory properties of aspartate transcarbamylase. , 1983, Archives of biochemistry and biophysics.

[29]  A. Bach.  [Carnitine biosynthesis in mammals]. , 1982, Reproduction, nutrition, developpement.

[30]  R. Hauhart,et al.  Taurine: possible role in osmotic regulation of mammalian heart. , 1981, Science.

[31]  L. Kaijser,et al.  Regulation of glycolysis in intermittent exercise in man. , 1978, The Journal of physiology.

[32]  G. Stark,et al.  Purification from hamster cells of the multifunctional protein that initiates de novo synthesis of pyrimidine nucleotides. , 1977, The Journal of biological chemistry.

[33]  P. Sugden,et al.  Effect of citrate on the activities of 6-phosphofructokinase from nervous and muscle tissues from different animals and its relationships to the regulation of glycolysis. , 1977, The Biochemical journal.

[34]  M. Mori,et al.  Aggregation states and catalytic properties of the multienzyme complex catalyzing the initial steps of pyrimidine biosynthesis in rat liver. , 1975, Biochemistry.

[35]  S. Tanaka,et al.  Human cytomegalovirus stimulates host cell RNA synthesis , 1975, Journal of virology.

[36]  M. E. Jones,et al.  Uridylic acid synthesis in Ehrlich ascites carcinoma. Properties, subcellular distribution, and nature of enzyme complexes of the six biosynthetic enzymes. , 1973, Biochemistry.

[37]  S. Plotkin,et al.  Growth Characteristics of Cytomegalovirus in Human Fibroblasts with Demonstration of Protein Synthesis Early in Viral Replication , 1973, Journal of virology.

[38]  K. Ito,et al.  Control of pyrimidine biosynthesis in mammalian tissues. II. Glutamine-utilizing carbamoyl phosphate synthetase of various experimental tumors: distribution, purification and characterization. , 1970, Biochimica et biophysica acta.

[39]  K. Ito,et al.  Control of pyrimidine biosynthesis in mammalian tissues. I. Partial purification and characterization of glutamine-utilizing carbamyl phosphate synthetase of mouse spleen and its tissue distribution. , 1969, The Journal of biological chemistry.